Tokyo court rejects Shire claim against Roche hemophilia drug

ZURICH (Reuters) - A Tokyo court has ruled that Shire's claim against Swiss drugmaker Roche's new Hemlibra hemophilia medicine should be dismissed, Roche's Japanese subsidiary Chugai said on Wednesday, helping to clear up legal uncertainty over the prospective blockbuster medicine.

from Reuters: Health News https://ift.tt/2pLEzWd